4//SEC Filing
BERTOCCI DEREK A 4
Accession 0001628280-20-013066
CIK 0001576280other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:57 PM ET
Size
18.0 KB
Accession
0001628280-20-013066
Insider Transaction Report
Form 4
BERTOCCI DEREK A
Chief Financial Officer
Transactions
- Exercise/Conversion
COMMON STOCK
2020-08-24$8.80/sh+2,306$20,293→ 46,465 total - Sale
COMMON STOCK
2020-08-24$93.04/sh−2,203$204,966→ 44,262 total - Sale
COMMON STOCK
2020-08-24$95.02/sh−3,795$360,583→ 36,913 total - Sale
COMMON STOCK
2020-08-24$94.34/sh−3,554$335,293→ 40,708 total - Sale
COMMON STOCK
2020-08-24$96.05/sh−440$42,261→ 36,473 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2020-08-24−2,306→ 18,445 totalExercise: $8.80Exp: 2028-08-21→ COMMON STOCK (2,306 underlying) - Exercise/Conversion
COMMON STOCK
2020-08-24$3.63/sh+7,686$27,900→ 44,159 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2020-08-24−7,686→ 0 totalExercise: $3.63Exp: 2026-07-26→ COMMON STOCK (7,686 underlying)
Footnotes (7)
- [F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $92.66 to $93.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $93.71 to $94.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $94.72 to $95.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $95.75 to $96.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The stock option vests and becomes exercisable as to 25% of the options on July 18, 2017, thereafter vests in equal monthly installments over 36 months.
- [F7]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001206964
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:57 PM ET
- Size
- 18.0 KB